1471249-89-4

Upstream product

• 1470310-66-7 (S)-2-(2-amino-7-(4-chlorophenyl)-5-methylbenzo[d]thiazol-6-yl)-2-tert-butoxyethyl pivalate 
• 1470311-08-0 (S)-2-(2-bromo-7-(4-chlorophenyl)-5-methylbenzo[d]thiazol-6-yl)-2-tert-butoxyethyl pivalate 
• 1471256-52-6 (S)-2-(2-(3-bromophenyl)-7-(4-chlorophenyl)-5-methylbenzo[d]thiazol-6-yl)-2-tert-butoxyacetic acid 
• 1403666-52-3 (S)-2-(4-amino-2-bromo-6-methylphenyl)-2-tert-butoxyethyl pivalate 
• 1403666-51-2 (S)-2-(2-bromo-6-methyl-4-nitrophenyl)-2-tert-butoxyethyl pivalate 
• 1403666-50-1 (S)-2-(2-bromo-6-methyl-4-nitrophenyl)-2-hydroxyethyl pivalate 
• 1403666-49-8 (S)-1-(2-bromo-6-methyl-4-nitrophenyl)ethane-1,2-diol 
• 1403666-48-7 1-bromo-3-methyl-5-nitro-2-vinylbenzene 
• 1403666-47-6 2-bromo-6-methyl-4-nitrophenyl trifluoromethanesulfonate 
• 99-53-6 2-methyl-4-nitrophenol 
• 4186-49-6 2-bromo-6-methyl-4-nitrophenol 
• 1471256-51-5 (S)-2-(2-(3-bromophenyl)-7-(4-chlorophenyl)-5-methylbenzo[d]thiazol-6-yl)-2-tert-butoxyethanol 

Relevant academic research and scientific papers

THERAPEUTIC COMPOUNDS

Compounds disclosed herein including compounds of formula I′: and salts thereof are provided. Pharmaceutical compositions comprising compounds disclosed herein, processes for preparing compounds disclosed herein, intermediates useful for preparing compounds disclosed herein and therapeutic methods for treating an HIV infection using compounds disclosed herein are also provided.